Skip to content

The Impact of Two Different Insulin Dose Calculation on Postprandial Glycemia After Mixed Meal.

The Impact of Two Different Insulin Dose Calculation on Postprandial Glycemia After Mixed Meal in Children With Type 1 Diabetes Mellitus- Randomized Study.

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04124302
Enrollment
76
Registered
2019-10-11
Start date
2019-10-01
Completion date
2024-12-31
Last updated
2025-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus, Type 1

Keywords

diabetes type 1, insulin bolus, prandial insulin requirement, postprandial glycemia, insulin pump therapy, mixed meal

Brief summary

The aim of the study is to compare the impact of two different insulin dose calculation on postprandial glycemia after mixed meal in children with type 1 diabetes mellitus.

Interventions

DRUGInsulin Glulisine

A kind of bolus insulin will be insulin glulisine if participant used insulin glulisine before entering the trial.

DRUGInsulin Aspart

A kind of bolus insulin will be insulin aspart if participant used insulin aspart before entering the trial.

DRUGInsulin Lispro

A kind of bolus insulin will be insulin lispro if participant used insulin lispro before entering the trial.

Sponsors

Medical University of Warsaw
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
10 Years to 18 Years
Healthy volunteers
No

Inclusion criteria

* duration of type 1 diabetes longer than 12 months * insulin pump therapy longer than 3 months * treated by the same type of insulin longer than 3 months * written informed consent by patients and parents

Exclusion criteria

* celiac disease * diabetes related complications (e.g. nephropathy) * any disease judged by the investigator to affect the trial * withdrawal of consent to participate in the study

Design outcomes

Primary

MeasureTime frameDescription
Postprandial glycemia30 minutes after mealPostprandial blood glucose excursion measured by self monitoring of blood glucose (SMBG).

Secondary

MeasureTime frameDescription
Hypoglycemia Episodes5 hours study periodHypoglycemia defined as a plasma glucose concentration below 70mg/dl with or without symptoms
Glucose Area Under the Curve (AUC)5 hours study periodMeasurements based on Continuous Glucose Monitoring System (CGMS)
The Difference Between The Maximum and Baseline Glucose Level - mean amplitude of glycaemic excursion (MAGE)5 hours study periodMeasurements based on SMBG
Time in target postprandial glycemia5 hours study periodTime spent in the target range between 70 and 180 mg/dL based on CGMS

Countries

Poland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026